Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Diarrhea Incidence

Doses used in studies

CFU/day: 100 million–200 million (median 100 million, IQR 100 million–150 million) — 3 studies

1 of 1 paper

The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence
- 2014-05-13
- Systematic Review
- European Journal of Pediatrics 173(10)
- - M. Urbańska
  - H. Szajewska
- PubMed: 24819885
- DOI: 10.1007/s00431-014-2328-0
6 Insights on
- Reduced Diarrhea Incidence
- High evidence
- Highly Cited
There is some evidence that L. reuteri is effective in reducing the incidence of diarrhea in children attending day care centers.
Effect
Beneficial
Effect size
Moderate